类风湿关节炎与非类风湿关节炎患者心血管风险算法的比较及C反应蛋白的预测作用
该回顾性分析比较FRS和QRISK2在RA与非RA患者中的心血管风险预测性能,并评估加入CRP能否提升预测。结果显示两种算法在非RA队列的C指数均显著优于RA队列;在RA队列中加入CRP对C指数改善微小,NRI无显著提升。
要点
- FRS与QRISK2在非RA患者中的C指数均显著高于RA患者。
- 在RA患者中,log[CRP]与心血管事件正相关。
- 在RA队列中加入CRP后,FRS与QRISK2的NRI均无显著改善。
核心结论
- FRS和QRISK2在非RA患者中的C指数显著优于RA患者。
- 在两种算法中加入CRP均未带来基于NRI的显著重分类改善。
研究设计与样本
- 采用回顾性分析,使用与英国HES数据链接的临床实践数据集。
- 将至少有一个RA诊断码且无既往心血管事件的患者,通过疾病风险评分匹配非RA患者。
主要发现
- FRS在非RA与RA队列的C指数分别为0.783与0.754(P < 0.001)。
- QRISK2在非RA与RA队列的C指数分别为0.770与0.744(P < 0.001)。
- log[CRP]与心血管事件呈正相关。
- 加入CRP后FRS的C指数从0.764升至0.767(P = 0.026),QRISK2从0.764升至0.765(P = 0.250)。
- FRS的NRI为3.2%(95% CI: -2.8, 5.7%),QRISK2的NRI为-2.0%(95% CI: -5.8, 4.5%)。
关键数值与推荐
- FRS在非RA与RA队列的C指数分别为0.783与0.754(P < 0.001)。
- QRISK2在非RA与RA队列的C指数分别为0.770与0.744(P < 0.001)。
- FRS加入CRP后C指数从0.764升至0.767(P = 0.026)。
- QRISK2加入CRP后C指数从0.764升至0.765(P = 0.250)。
- FRS的NRI为3.2%(95% CI: -2.8, 5.7%),QRISK2的NRI为-2.0%(95% CI: -5.8, 4.5%)。
临床怎么用
- 在RA患者中应用FRS或QRISK2评估心血管风险时,需注意其区分能力低于非RA人群。
- 在RA患者中常规加入CRP以提升FRS或QRISK2预测性能的依据不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aims were to compare the performance of cardiovascular risk calculators, Framingham Risk Score (FRS) and QRISK2, in RA and matched non-RA patients and to evaluate whether their performance could be enhanced by the addition of CRP. METHODS: We conducted a retrospective analysis, using a clinical practice data set linked to Hospital Episode Statistics (HES) data from the UK. Patients presenting with at least one RA diagnosis code and no prior cardiovascular events were matched to non-RA patients using disease risk scores. The overall performance of the FRS and QRISK2 was compared between cohorts, and assessed with and without CRP in the RA cohort using C-Index, Akaike Information Criterion (AIC) and the net reclassification index (NRI). RESULTS: Four thousand seven hundred and eighty RA patients met the inclusion criteria and were followed for a mean of 3.8 years. The C-Index for the FRS in the non-RA and RA cohort was 0.783 and 0.754 (P < 0.001) and that of the QRISK2 was 0.770 and 0.744 (P < 0.001), respectively. Log[CRP] was positively associated with cardiovascular events, but improvements in the FRS and QRISK2 C-Indices as a result of inclusion of CRP were small, from 0.764 to 0.767 (P = 0.026) for FRS and from 0.764 to 0.765 (P = 0.250) for QRISK2. The NRI was 3.2% (95% CI: -2.8, 5.7%) for FRS and -2.0% (95% CI: -5.8, 4.5%) for QRISK2. CONCLUSION: The C-Index for the FRS and QRISK2 was significantly better in the non-RA compared with RA patients. The addition of CRP in both equations was not associated with a significant improvement in reclassification based on NRI.
引用
- Alemao E, Cawston H, Bourhis F, et al. Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis. Rheumatology (Oxford). 2017. PMID: 28087832. doi:10.1093/rheumatology/kew440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。